Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.69 |
| ▸ | THRB | P10828 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.69 |
| ▸ | MAPT | P10636 | 4/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.69 |
| ▸ | HTT | P42858 | 3/20 | 0.69 |
| ▸ | TP53 | P04637 | 3/20 | 0.69 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.69 |
| ▸ | RECQL | P46063 | 2/20 | 0.69 |
| ▸ | BLM | P54132 | 2/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.69 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.69 |
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | EGFR | P00533 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL25280 | 0.97 | TDP1 (0.70) | TDP1MAPK1THRBMEN1KMT2A | |
| Zinc Chloride SCHEMBL29577877 | 0.94 | TDP1 (0.65) | TDP1MAPK1THRBMEN1KMT2A | |
| Zinc Chloride SCHEMBL29837408 | 0.93 | TDP1 (0.64) | TDP1MAPK1THRBMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL25301058 | 0.85 | TDP1 (0.80) | TDP1MAPK1THRBMEN1KMT2A | |
| Zinc Ion SCHEMBL29366028 | 0.85 | TDP1 (0.75) | TDP1MAPK1THRBMEN1KMT2A | |
| Hexamethyl Pararosaniline SCHEMBL94116 | 0.84 | TDP1 (0.96) | TDP1MAPK1THRBMEN1KMT2A | |
| Hexamethyl Pararosaniline SCHEMBL9171 | 0.83 | TDP1 (1.00) | TDP1MAPK1THRBMEN1KMT2A | |
| SCHEMBL889789 | 0.81 | TDP1 (0.44) | TDP1MAPK1THRBMEN1KMT2A | |
| SCHEMBL14356079 | 0.79 | MEN1 (0.41) | TDP1MAPK1THRBMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL5452767 | 0.79 | TDP1 (0.61) | TDP1MAPK1THRBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7939644-B2 | cationic dyes used for coloring plastics, fibers, leather and paper, for the preparation of flexographic printing inks, as ball-point pen pastes, as stamp inks, for use in data acquisition systems, reprography, in ink microfilters, in photogalvanics, laser technology and the photo industry | MERCK PATENT GMBH (DE) | 2011-05-10 | — | — | US | disclosed |
| US-7794945-B2 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | ELITECH HOLDING B.V. (NL) | 2010-09-14 | — | — | US | disclosed |
| US-7556923-B1 | Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders | EPOCH BIOSCIENCES, INC. (US) | 2009-07-07 | — | — | US | disclosed |
| US-20090048427-A1 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | EPOCH BIOSCIENCES, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20080275224-A1 | Cyanoborate, Fluoroalkylphosphate, Fluoroalkylborate or Imide Dyes | MERCK PATENT GMBH (DE) | 2008-11-06 | — | — | US | disclosed |
| US-20080009060-A1 | Methods of discovering chemicals capable of functioning as gene expression modulators | FOULKES J G | 2008-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090048427-A1 | HYBRIDIZATION AND MISMATCH DISCRIMINATION USING OLIGONUCLEOTIDES CONJUGATED TO MINOR GROOVE BINDERS | DDB1, LIG3, MSH2 | TDP1 1394/4885MAPK1 4789/4885THRB 1562/4885 |
| US-20080275224-A1 | Cyanoborate, Fluoroalkylphosphate, Fluoroalkylborate or Imide Dyes | ZAP70, MYLK3, KIT | TDP1 980/4885MAPK1 1205/4885THRB 2374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.